UroGen Pharma urogen.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

UroGen Pharma (NASDAQ: URGN), fka Theracoat, is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The lead drug candidates, MitoGel and VesiGel, are designed to potentially remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade bladder cancer and low-grade upper tract urothelial carcinoma, or UTUC. In ad...Show all

UroGen Pharma (NASDAQ: URGN), fka Theracoat, is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The lead drug candidates...Show all

Company (IPO / Went public)

All investors data 2 Investors

Phone: +972-9-7707600

Fax:

9 Ha’Ta’asiya St

 Ra'anana, 4365007
 Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
UroGen Pharma $7M May 4, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related UroGen Pharma Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

Name Firm
Login to see detailsTwo River Group Holdings
Login to see detailsTeva Pharmaceuticals
Login to see detailsPontifax
Login to see detailsArkin Bioventures
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Immunomodulating treatments of body cavities Mar 11, 2019 Sep 01, 2020 Patent
Material and method for treating internal cavities Oct 15, 2013 Nov 12, 2019 Patent
Material and method for treating internal cavities May 22, 2015 Aug 07, 2018 Patent
Material and method for treating internal cavities Dec 01, 2016 Apr 24, 2018 Patent
Methods for treatment of bladder cancer Apr 10, 2015 Feb 06, 2018 Patent
See all 14 patents